Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: PF03512676|OTHER: Correlative Studies
Sponsor: Bhuvaneswari Ramaswamy
Collaborators: Pfizer